These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28763860)

  • 1. [Role of enolase 1 in hepatocellular carcinoma and possible mechanism].
    Yan TT; Ma LN; Luo X; Lu ZH; Liu Q; Xu YH; Liu XL; Ding XC
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):429-434. PubMed ID: 28763860
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells.
    Chen X; Xu H; Wu N; Liu X; Qiao G; Su S; Tian Y; Yuan R; Li C; Liu X; Lin X
    Oncotarget; 2017 May; 8(18):30305-30316. PubMed ID: 28415822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma.
    Zhu X; Yu H; Li B; Quan J; Zeng Z; Li G; Liu J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 30541900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1.
    Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X
    Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis.
    Jiang K; Dong C; Yin Z; Li R; Mao J; Wang C; Zhang J; Gao Z; Liang R; Wang Q; Wang L
    Cell Death Dis; 2020 Nov; 11(11):972. PubMed ID: 33184263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
    Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
    Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enolase-1 is a therapeutic target in endometrial carcinoma.
    Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
    Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect and mechanism of siRNA targeting α-enolase gene combined with paclitaxel on proliferation, invasion and apoptosis of hepatocellular carcinoma cell].
    Cui H; Gao QQ; Zhuang H; He T; Wan BS; Wang XQ; Zhang L; Huang T; Han F
    Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1241-1247. PubMed ID: 34915631
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
    Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
    Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of ENO1 inhibits the proliferation, migration and invasion of human breast cancer cells.
    Zhang J; Li H; Miao L; Ding J
    J BUON; 2020; 25(2):696-701. PubMed ID: 32521855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of α-enolase affects the biological activity of breast cancer cells by attenuating PI3K/Akt signaling pathway.
    Zang HY; Gong LG; Li SY; Hao JG
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):249-257. PubMed ID: 31957838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
    Yuan S; Lei S; Wu S
    Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
    Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
    J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
    White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
    Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells.
    Yuan Y; Yuan HF; Geng Y; Zhao LN; Yun HL; Wang YF; Yang G; Zhang XD
    Biochem Biophys Res Commun; 2021 Jun; 560():172-178. PubMed ID: 34000466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.